Clin2
NCT06015776Possibly a fitRecruiting

Heart cell signals after menopause

Diastolic Heart FailureHeart Failure With Preserved Ejection Fraction

Part of Heart & circulation clinical trials.

This trial studies how heart cells communicate after menopause. Researchers are looking at a chemical signal called purinergic signaling during heart surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
30 years to 88 years
Study type
Observational

Who can take part

  • You are scheduled for heart surgery that uses a heart-lung machine
  • You are a woman who has gone through menopause
  • You have not had this type of heart surgery before
  • You do not have a pacemaker or atrial fibrillation
  • You do not take estrogen or hormone replacement therapy
  • You do not have chronic heart failure or major kidney disease

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02820233Recruiting
Study of a heart-signal drug during bypass surgery

This study looks at a treatment that affects signals between heart cells in people with severe coronary artery disease who are scheduled for bypass surgery. The goal is to see if changing these heart-cell signals can improve heart outcomes around the time of surgery.

Portland, Maine
NCT06866119Recruiting
Estrogen and heart health in women with early menopause

This study looks at how estrogen therapy affects heart health in women with primary ovarian insufficiency (early menopause). Participants will take a standard estrogen patch and progesterone pill, and researchers will monitor their heart function over time.

Boston, Massachusetts
NCT07242391Recruiting
Menopausal hormone therapy and heart function study

This study looks at how menopausal hormone therapy might affect the heart's pumping ability. It may help women who are naturally entering menopause understand if hormone therapy can protect their heart health.

Rochester, Minnesota
NCT07394049Not yet recruiting
Hormone therapy and heart health in menopause

This study looks at how current hormone therapy for menopause affects heart health in women with higher heart risk. It may help doctors understand the safest ways to use these treatments.

Berlin
NCT07703124Not yet recruiting
Heart health study for women in menopause transition

This study looks at how menopause and related factors affect heart health in women. It aims to find ways to keep hearts healthy as women go through this transition, and may help guide early actions to reduce heart risk.

NCT05647876Recruiting
Study how menopause affects heart health risk over time

This study follows people through menopause to better understand how the body changes and how that may affect heart health risk. You may be asked for health checks over time, as researchers look for factors that increase or protect against heart problems.

Copenhagen

Hear when a new Heart Failure With Preserved Ejection Fraction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.